BR112023026246A2 - Modificação de pacotes mensageiros de planta - Google Patents

Modificação de pacotes mensageiros de planta

Info

Publication number
BR112023026246A2
BR112023026246A2 BR112023026246A BR112023026246A BR112023026246A2 BR 112023026246 A2 BR112023026246 A2 BR 112023026246A2 BR 112023026246 A BR112023026246 A BR 112023026246A BR 112023026246 A BR112023026246 A BR 112023026246A BR 112023026246 A2 BR112023026246 A2 BR 112023026246A2
Authority
BR
Brazil
Prior art keywords
plant
modification
cellular absorption
packages
plant messenger
Prior art date
Application number
BR112023026246A
Other languages
English (en)
Inventor
Mohammad Mosaheb Munir
Lvovitch Bogorad Roman
Dilipkumar Patel Siddharth
Original Assignee
Flagship Pioneering Innovations Vi Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flagship Pioneering Innovations Vi Llc filed Critical Flagship Pioneering Innovations Vi Llc
Publication of BR112023026246A2 publication Critical patent/BR112023026246A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6927—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
    • A61K47/6929—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H1/00—Processes for modifying genotypes ; Plants characterised by associated natural traits
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Nanotechnology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Environmental Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Botany (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

modificação de pacotes mensageiros de planta. a presente invenção refere-se a composições que incluem uma pluralidade de pacotes mensageiros de plantas (por exemplo, incluindo uma vesícula extracelular (ve) de planta ou segmento, porção ou extrato da mesma), que são modificados para terem absorção celular intensificada (por exemplo, absorção celular vegetal e animal, absorção celular bacteriana ou absorção celular fúngica), por exemplo, para uso em uma variedade de métodos agrícolas ou terapêuticos.
BR112023026246A 2021-06-14 2022-06-14 Modificação de pacotes mensageiros de planta BR112023026246A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163210464P 2021-06-14 2021-06-14
PCT/US2022/033433 WO2022266096A1 (en) 2021-06-14 2022-06-14 Modification of plant messenger packs

Publications (1)

Publication Number Publication Date
BR112023026246A2 true BR112023026246A2 (pt) 2024-02-27

Family

ID=84527418

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023026246A BR112023026246A2 (pt) 2021-06-14 2022-06-14 Modificação de pacotes mensageiros de planta

Country Status (9)

Country Link
EP (1) EP4355890A1 (pt)
JP (1) JP2024520863A (pt)
KR (1) KR20240044415A (pt)
CN (1) CN117836422A (pt)
AU (1) AU2022295939A1 (pt)
BR (1) BR112023026246A2 (pt)
CA (1) CA3223590A1 (pt)
IL (1) IL309247A (pt)
WO (1) WO2022266096A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023122080A1 (en) * 2021-12-20 2023-06-29 Senda Biosciences, Inc. Compositions comprising mrna and lipid reconstructed plant messenger packs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8969353B2 (en) * 2008-11-07 2015-03-03 Massachusetts Institute Of Technology Aminoalcohol lipidoids and uses thereof
EP3727428A1 (en) * 2017-12-20 2020-10-28 Translate Bio, Inc. Improved composition and methods for treatment of ornithine transcarbamylase deficiency
EA202190368A1 (ru) * 2018-08-24 2021-06-10 ФЛЭГШИП ПАЙОНИРИНГ ИННОВЕЙШНЗ VI, ЭлЭлСи Модифицированные пакеты-мессенджеры растений и варианты их применения
US20220304930A1 (en) * 2019-08-24 2022-09-29 Flagship Pioneering Innovations Vi, Llc Modification of plant messenger packs with charged lipids

Also Published As

Publication number Publication date
KR20240044415A (ko) 2024-04-04
JP2024520863A (ja) 2024-05-24
WO2022266096A1 (en) 2022-12-22
IL309247A (en) 2024-02-01
EP4355890A1 (en) 2024-04-24
CA3223590A1 (en) 2022-12-22
AU2022295939A1 (en) 2024-01-18
CN117836422A (zh) 2024-04-05

Similar Documents

Publication Publication Date Title
BR112022003021A2 (pt) Modificação de pacotes mensageiros de plantas com lipídeos carregados
MX2020009320A (es) Uso de compuestos heteroarilo-triazol y heteroarilo-tetrazol como plaguicidas para la proteccion de plantas.
BR112019024264A2 (pt) Antimitoscinas: inibidores direcionados da biogênese mitoconcrial para erradicação de células-tronco de câncer
CL2023001410A1 (es) Paquetes mensajeros vegetales modificados y usos de los mismos
BRPI0608402A2 (pt) compostos de flavonóide e usos dos mesmos
CL2020000632A1 (es) Composición y método para el tratamiento del autismo.
DOP2010000304A (es) Composiciones y metodos de preparacion y uso de las mismas
BR112012030581A2 (pt) pseudozyma aphidis como um agente de biocontrole contra vários patógenos de plantas
CL2022002963A1 (es) Anticuerpos de cadena pesada multiespecíficos con regiones constantes de cadena pesada modificadas
BR112018005489A2 (pt) composição bioestimulante baseada em taninos e/ou seus derivados para o tratamento de plantas cultivadas e/ou suas partes
CL2020000866A1 (es) Uso de composiciones que contienen streptomyces melanosporofaciens agl225 en el control de enfermedades de las plantas.
BR112021020975A2 (pt) Composições e métodos relacionados com pacotes de mensageiros de plantas
DOP2022000229A (es) Anticuerpos de cadena pesada multiespecíficos con regiones constantes de cadena pesada modificadas
BR112023026246A2 (pt) Modificação de pacotes mensageiros de planta
CL2021003291A1 (es) Mezcla de extractos de plantas para su uso en la prevención y/o tratamiento de enfermedades inflamatorias crónicas del intestino.
CO2023006684A2 (es) Anticuerpos contra sars-cov-2 y usos de los mismos
CL2023000491A1 (es) Composiciones de erenumab y usos de las mismas (divisional de solicitud n° 02519-2020).
BR112016001742A2 (pt) composições fungicidas e seu uso
BR112021023845A2 (pt) Complexos macromoleculares de fungicida de ditiocarbamato
AR115359A1 (es) Preparaciones microbianas para plantas, composiciones y formulaciones que las comprenden y sus usos
CL2020002646A1 (es) Composición para modular genes responsables de las funciones generales de la piel, que comprende al menos un extracto vegetal seleccionado de casearia sylvestris y schinus terebinthfolius y ácido hialurónico (divisional de la solicitud 03354-2018)
UY37693A (es) Método para mejorar la seguridad de los cultivos
BR112023024034A2 (pt) Polipeptídeos de sars-cov-2
ES2422423T3 (es) Usos cosméticos y farmacéuticos de un extracto de las semillas de Buchholzia coriacea
BR112016017214A8 (pt) composição antifúngica, uso da mesma, composição agroquímica, método para tratar, atenuar ou prevenir uma doença ou infecção agroquímica em uma planta e composição farmacêutica antifúngica